TARGAN is a Biotech company based in Raleigh/Morrisville. It has raised $150M in total funding. Latest round: Growth.
TARGAN funding overview
TARGAN is a Biotech company based in Raleigh/Morrisville. TARGAN has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in March 2026. The round record for TARGAN runs through 2026; nothing later has been disclosed. Investors on record include Symbiotic Capital, Mountain Group Partners, Merck Animal Health, Oval Park Capital. 4 distinct backers are named across the disclosed rounds.
TARGAN at a glance
Total raised
$150M
Latest round
Growth
Latest round date
March 2026
Industry
Biotech
Headquarters
Raleigh/Morrisville
Notable investors
Symbiotic Capital, Mountain Group Partners, Merck Animal Health, Oval Park Capital
Frequently asked about TARGAN funding
How much has TARGAN raised?
TARGAN has raised $150M in total disclosed funding across the rounds on record.
Who has invested in TARGAN?
Symbiotic Capital, Mountain Group Partners, Merck Animal Health, Oval Park Capital are named among the investors backing TARGAN.
What was the latest TARGAN funding round?
The most recent disclosed round is a Growth, announced in March 2026.
Where is TARGAN based?
TARGAN is based in Raleigh/Morrisville.
What sector does TARGAN operate in?
TARGAN is tracked under Biotech from Raleigh/Morrisville, with $150M in disclosed funding.
When did TARGAN last raise?
The last disclosed TARGAN round closed in March 2026 at Growth.
Totals shown for TARGAN aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Raleigh/Morrisville and the investors behind them below.
